Amy Miles - Amgen Independent Director
| AMGN34 Stock | BRL 60.11 0.07 0.12% |
Insider
Amy Miles is Independent Director of Amgen Inc since 2020.
| Age | 52 |
| Tenure | 4 years |
| Phone | 805 447 1000 |
| Web | https://www.amgen.com |
Amy Miles Latest Insider Activity
Tracking and analyzing the buying and selling activities of Amy Miles against Amgen stock is an integral part of due diligence when investing in Amgen. Amy Miles insider activity provides valuable insight into whether Amgen is net buyers or sellers over its current business cycle. Note, Amgen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amgen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Amy Miles over six months ago Disposition of 33006 shares by Amy Miles of Regencell Bioscience at 21.58 subject to Rule 16b-3 |
Amgen Management Efficiency
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard Esq | Dell Technologies | 59 | |
| Joachim Ante | Unity Software | 41 | |
| Michael Zimmerman | Dell Technologies | N/A | |
| CFA Davis | Unity Software | N/A | |
| Scott DeBoer | Micron Technology | 57 | |
| Michael Bokan | Micron Technology | 62 | |
| Sanjay Mehrotra | Micron Technology | 64 | |
| Marc Whitten | Unity Software | 52 | |
| Anand Bahl | Micron Technology | N/A | |
| Rob Beard | Micron Technology | N/A | |
| Luis Visoso | Unity Software | 54 | |
| Mark Murphy | Micron Technology | 55 | |
| Rafael Gorenstein | Lupatech SA | N/A | |
| Sumit Sadana | Micron Technology | 54 | |
| Allison Dew | Dell Technologies | 53 | |
| Paulo Silva | Lupatech SA | N/A | |
| Jeffrey Clarke | Dell Technologies | 60 | |
| John Riccitiello | Unity Software | 63 | |
| Anthony Whitten | Dell Technologies | 47 | |
| Michael Dell | Dell Technologies | 58 | |
| Anirma Gupta | Unity Software | N/A | |
Management Performance
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Linda Louie, Vice President - Finance, Chief Accounting Officer | ||
| Nancy Grygiel, Sr Officer | ||
| David Reese, Executive Vice President - Research and Development | ||
| Tyler Jacks, Independent Director | ||
| Gregory Garland, Independent Director | ||
| Charles Holley, Independent Director | ||
| Esteban Santos, Executive Vice President Operations | ||
| Jonathan Graham, Senior Vice President General Counsel, Secretary | ||
| Mike Zahigian, VP Officer | ||
| Ellen Kullman, Independent Director | ||
| Arvind Sood, IR Contact Officer | ||
| Ronald Sugar, Independent Director | ||
| Robert Bradway, Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee | ||
| Murdo Gordon, Executive Vice President of Global Commercial Operations | ||
| Peter Griffith, Chief Financial Officer, Executive Vice President | ||
| Wanda Austin, Independent Director | ||
| Robert Eckert, Lead Independent Director | ||
| Lori Johnston, Senior Vice President - Human Resources | ||
| Brian Druker, Independent Director | ||
| Cynthia Patton, Senior Vice President Chief Compliance Officer | ||
| Robert Williams, Independent Director | ||
| Amy Miles, Independent Director | ||
| Fred Hassan, Independent Director | ||
| David Piacquad, Senior Vice President - Business Development | ||
| David MD, Ex RD |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 910.32 B | |||
| Shares Outstanding | 14.95 B | |||
| Price To Earning | 0.83 X | |||
| Price To Book | 39.25 X | |||
| Price To Sales | 29.10 X | |||
| Revenue | 26.32 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..